HealthyDirect · GrowthFit for a long SIP
Old Bridge Focused Fund
Old Bridge Mutual FundEquity Scheme - Focused Fund2.8 years
The scheme seeks to generate long-term capital appreciation by investing in equity and equity related instruments of up to 30 companies across market capitalization (i.e. Mid cap, Small cap, Large cap).
- NAV
- 12.99
- 30 Oct 2026
- 1Y
- +5.3%
- Trailing CAGR
- AUM
- ₹4,541.99 Cr
- 30 Sept 2026
- Volatility
- High
- 16.2% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 77% of rolling 1-year windows.
Buy checklist
History depth
Fail
2.8 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.11% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.9%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Pass
Kenneth Andrade · 2.8 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 55.9% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 19%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+5.3%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+9.9%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+2.2%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +9.9%
- Calendar-day CAGR
- Excess 1Y
- +9.8%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -18.9%
- Worst peak-to-trough
- Current
- -9.7%
- Below last peak
- Current spell
- 81 days
- Days below latest peak
- Time below peak
- +89%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 15 days
- 31 recovered episodes
- Longest recovery
- 312 days
- Trough to prior peak
23 Sept 2024 – 6 Jan 2026
Trough 28 Feb 2025 · recovered in 312 days
-18.9%
6 Jan 2026 – 6 May 2026
Trough 23 Mar 2026 · recovered in 44 days
-13.0%
10 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-11.5%
23 Feb 2024 – 2 Apr 2024
Trough 13 Mar 2024 · recovered in 20 days
-7.3%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
34
Vs category
100
Consistency
77
Risk-adjusted
41
Drawdown
53
Mean
61
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 77% of rolling 1-year windows.
Portfolio
30 Sept 2026 · 27 holdings · top 10 are 55.9%.
- Top 5
- 33.8%
- Top 10
- 55.9%
- Largest holding
- 9.1%
- Effective holdings
- 21.0
Repo
Unspecified
9.1%
Shriram Transport Finance Company Ltd
Financial
7.2%
Redington Ltd
Technology
7.0%
Aurobindo Pharma Ltd
Healthcare
5.6%
Interglobe Aviation Ltd
Industrials
5.0%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Edelweiss Focused Fund
Edelweiss Mutual Fund
- 1Y
- -7.8%
- 3Y
- +11.8%
- Vol
- 13.8%
- Max DD
- -17.1%
- Sharpe
- 0.51
- 3Y win
- +90%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
ITI Focused Fund
ITI Mutual Fund
- 1Y
- -0.5%
- 3Y
- +16.1%
- Vol
- 15.6%
- Max DD
- -18.4%
- Sharpe
- 0.66
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Aditya Birla Sun Life Focused Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- -3.2%
- 3Y
- +13.2%
- Vol
- 15.6%
- Max DD
- -36.7%
- Sharpe
- 0.56
- 3Y win
- +33%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Quant Focused Fund
quant Mutual Fund
- 1Y
- +2.4%
- 3Y
- +14.0%
- Vol
- 16.7%
- Max DD
- -36.4%
- Sharpe
- 0.65
- 3Y win
- +78%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER
SBI FOCUSED FUND
SBI Mutual Fund
- 1Y
- +4.0%
- 3Y
- +15.2%
- Vol
- 13.6%
- Max DD
- -32.7%
- Sharpe
- 0.70
- 3Y win
- +65%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown